Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies: Influence Statistics

Expert Impact

Concepts for which they have has direct influence: Myotonia congenita , Ion channel , Clc1 mutation , Ion channelopathies , Muscle clc1 , Molecular dynamics simulations , Mutation myotonia .

Key People For Myotonia Congenita

Top KOLs in the world
#1
Frank Lehmann‐Horn
malignant hyperthermia skeletal muscle paramyotonia congenita
#2
Kenneth W Ricker
paramyotonia congenita myotonic dystrophy type myasthenia gravis
#3
Alfred L George
sodium channel paramyotonia congenita skeletal muscle
#4
Manuela C Koch
myotonic dystrophy myotonia congenita genetic counseling
#5
Thomas J Jentsch
chloride channels potassium channel xenopus oocytes
#6
Klaus Steinmeyer
chloride channel xenopus oocytes cell cycle

Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies

Abstract

. Myotonia congenita is an inherited disease that is characterized by impaired muscle relaxation after contraction caused by loss-of-function mutations in the skeletal muscle ClC-1 channel. We report a novel ClC-1 mutation, T335N, that is associated with a mild phenotype in 1 patient, located in the extracellular I-J loop. The purpose of this study was to provide a solid correlation between T335N dysfunction and clinical symptoms in the affected patient as well as to offer hints for drug development. Our multidisciplinary approach includes patch-clamp electrophysiology on T335N and ClC-1 wild-type channels expressed in tsA201 cells, Western blot and quantitative PCR analyses on muscle biopsies from patient and unaffected individuals, and molecular dynamics simulations using a homology model of the ClC-1 dimer. T335N channels display reduced chloride currents as a result of gating alterations rather than altered surface expression. Molecular dynamics simulations suggest that the I-J loop might be involved in conformational changes that occur at the dimer interface, thus affecting gating. Finally, the gene expression profile of T335N carrier showed a diverse expression of K+ channel genes, compared with control individuals, as potentially contributing to the phenotype. This experimental paradigm satisfactorily explained myotonia in the patient. Furthermore, it could be relevant to the study and therapy of any channelopathy.-Imbrici, P., Altamura, C., Camerino, G. M., Mangiatordi, G. F., Conte, E., Maggi, L., Brugnoni, R., Musaraj, K., Caloiero, R., Alberga, D., Marsano, R. M., Ricci, G., Siciliano, G., Nicolotti, O., Mora, M., Bernasconi, P., Desaphy, J.-F., Mantegazza, R., Camerino, D. C. Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.